Data from the IBD trial any day now. Possible deal for brilacidin OM soon as well. These bios can be frustrating for the impatient. When something goes right, that's when we win. Last couple days the accumulation has been clear.
What KIND of news do you think would boost the share price by a penny? With that kind of a weak response from investors, it certainly would not be perceived a good news imo.